Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Clover Health Investments, Corp.

NASDAQ: CLOV · Finance · 16 alerts · CIK 1801170

Share price
$4.95Close, Nov 16
Sector
Finance
Industry
Hospital & Medical Service PlansSIC 6324

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Clover Health Investments, Corp. filings on SEC EDGAR ↗

6:35 PM ET 8-K
Business Update

Clover Health Investments Business Update

Clover Health published a supplemental Q&A document to address frequently asked shareholder questions following its third quarter 2026 earnings announcement. The update discusses long-term projections through 2028, membership cohort maturation, and plans to improve the company's Adjusted SG&A ratio through operating leverage as it scales.

8:03 AM ET 10-Q
Financial Results

Clover Health Investments Q3 2026 Results: Turns Profitable, Net Income $6.43M

Clover Health Investments, Corp. is a remote-first healthcare technology company that operates as a large accelerated filer. As of October 30, 2026, the company had 439,707,261 shares of Class A and 95,713,497 shares of Class B common stock outstanding. The filing highlights the expansion of its Clover Assistant technology under the brand name Counterpart Assistant for external payors and providers.

Key figure
Net income $6.43M
4:08 PM ET 8-K
Financial Results

Clover Health Investments Financial Results

Clover Health reported Q3 2026 financial results, achieving GAAP net income of $6 million and total revenue growth of 53% year-over-year to $759.3 million. The company raised its full-year 2026 guidance, now expecting total revenues between $2.97 billion and $3.00 billion and its first full year of GAAP net income profitability. Alongside the results, the company appointed Interim CFO Joseph Clay Thornton to the role on a permanent basis.

Term
Q3 2026

“Our results further demonstrate our technology-powered differentiation, and how earlier and better care management, market-leading growth, and increasing profitability can reinforce one another under the right model.”

Andrew Toy, Clover Health CEO

“In 2026, Clover is on track to have grown significantly and expects to deliver its first full year of GAAP Net Income profitability. With our largest member cohorts maturing, continued operating leverage, and strong Star ratings performance, we believe we are well positioned for meaningful earnings expansion in 2027.”

Clay Thornton, Clover Health CFO
5:57 PM ET Form 4
Insider Selling

Clover Health Investments CLO Karen Soares Sells $89.8K of Stock

Karen Soares, CLO, sold 19,275 shares of Clover Health Investments, Corp. at $4.66 a share, worth $89.8K in total on Oct 20, 2026. Shares held after the trade: 1,573,423 (-1.2%).

Value
$89.8K
Shares
19,275
Price
$4.66
Role
CLO
Holding change
-1.2%
Trade date
Oct 20, 2026
4:43 PM ET Form 4
Insider Selling

Clover Health Investments CEO, Medicare Advantage Jamie L. Reynoso Sells $17.9K of Stock

Jamie L. Reynoso, CEO, Medicare Advantage, sold 4,066 shares of Clover Health Investments, Corp. at $4.41 a share, worth $17.9K in total on Oct 19, 2026. Shares held after the trade: 2,770,351 (-0.1%).

Value
$17.9K
Shares
4,066
Price
$4.41
Role
CEO, Medicare Advantage
Holding change
-0.1%
Trade date
Oct 19, 2026
4:31 PM ET Form 4
Insider Selling

Clover Health Investments CEO Andrew Toy Sells $291K of Stock

Andrew Toy, CEO, sold 62,176 shares of Clover Health Investments, Corp. at $4.68 a share, worth $291K in total on Oct 15, 2026. Shares held after the trade: 9,078,334 (-0.7%).

Value
$291K
Shares
62,176
Price
$4.68
Role
CEO
Holding change
-0.7%
Trade date
Oct 15, 2026
4:26 PM ET Form 4
Insider Selling

Clover Health Investments CLO Karen Soares Sells $68.7K of Stock

Karen Soares, CLO, sold 14,673 shares of Clover Health Investments, Corp. at $4.68 a share, worth $68.7K in total on Oct 15, 2026. Shares held after the trade: 1,592,698 (-0.9%).

Value
$68.7K
Shares
14,673
Price
$4.68
Role
CLO
Holding change
-0.9%
Trade date
Oct 15, 2026
4:23 PM ET Form 4
Insider Selling

Clover Health Investments Interim CFO Joseph Clay Thornton Sells $21.5K of Stock

Joseph Clay Thornton, Interim CFO, sold 4,591 shares of Clover Health Investments, Corp. at $4.68 a share, worth $21.5K in total on Oct 15, 2026. Shares held after the trade: 1,244,935 (-0.4%).

Value
$21.5K
Shares
4,591
Price
$4.68
Role
Interim CFO
Holding change
-0.4%
Trade date
Oct 15, 2026
4:22 PM ET Form 4
Insider Selling

Clover Health Investments CEO, Counterpart Health Conrad Wai Sells $111K of Stock

Conrad Wai, CEO, Counterpart Health, sold 23,627 shares of Clover Health Investments, Corp. at $4.68 a share, worth $111K in total on Oct 15, 2026. Shares held after the trade: 1,042,072 (-2.2%).

Value
$111K
Shares
23,627
Price
$4.68
Role
CEO, Counterpart Health
Holding change
-2.2%
Trade date
Oct 15, 2026
4:19 PM ET Form 4
Insider Selling

Clover Health Investments CEO, Medicare Advantage Jamie L. Reynoso Sells $85.5K of Stock

Jamie L. Reynoso, CEO, Medicare Advantage, sold 18,273 shares of Clover Health Investments, Corp. at $4.68 a share, worth $85.5K in total on Oct 15, 2026. Shares held after the trade: 2,774,417 (-0.7%).

Value
$85.5K
Shares
18,273
Price
$4.68
Role
CEO, Medicare Advantage
Holding change
-0.7%
Trade date
Oct 15, 2026
6:02 AM ET 8-K
Business Update

Clover Health Investments Business Update

Clover Health announced that CMS awarded its PPO Medicare Advantage plans a 5-star rating and its HMO plan a 4.5-star rating for 2027. The 5-star rating for the PPO plans, which cover ~98% of the company's members, allows for year-round enrollment and higher quality-based payments in 2028. The rating calculation was impacted by a court decision removing 20 specific measures currently under appeal.

Counterparty
Centers for Medicare & Medicaid Services
Term
2027 Star Ratings (affecting payment year 2028)
7:01 PM ET Form 4
Insider Selling

Clover Health Investments CEO, Medicare Advantage Jamie L. Reynoso Sells $38.7K of Stock

Jamie L. Reynoso, CEO, Medicare Advantage, sold 8,750 shares of Clover Health Investments, Corp. at $4.42 a share, worth $38.7K in total on Oct 5, 2026. Shares held after the trade: 2,794,696 (-0.3%).

Value
$38.7K
Shares
8,750
Price
$4.42
Role
CEO, Medicare Advantage
Holding change
-0.3%
Trade date
Oct 5, 2026
4:13 PM ET Form 4
Insider Selling

Clover Health Investments CEO Andrew Toy Sells $1.34M of Stock

Andrew Toy, CEO, sold 318,806 shares of Clover Health Investments, Corp. at $4.19 a share, worth $1.34M in total on Oct 1, 2026. Shares held after the trade: 9,140,510 (-3.4%).

Value
$1.34M
Shares
318,806
Price
$4.19
Role
CEO
Holding change
-3.4%
Trade date
Oct 1, 2026
6:00 AM ET 8-K/A
Leadership Change

Clover Health Investments Leadership Change

Clover Health has appointed former U.S. Senator Robert Torricelli and Dr. Brian J. Miller to its Board of Directors, filling two previously disclosed vacancies. Senator Torricelli will serve on the Audit Committee, while Dr. Miller joins the Clinical Committee, bringing the total board count to nine directors. The appointments aim to strengthen the company's expertise in federal policy, clinical medicine, and Medicare Advantage regulation.

4:32 PM ET 8-K
Leadership Change

Clover Health Investments Leadership Change

Clover Health appointed former U.S. Senator Robert Torricelli and Dr. Brian J. Miller to its Board of Directors, filling two vacancies and bringing the board to nine members. Senator Torricelli will serve on the Audit Committee, while Dr. Miller joins the Clinical Committee, bringing expertise in federal policy, clinical medicine, and healthcare regulation. Both directors will receive pro-rated annual retainers and restricted stock units valued at $200,000 for their service through 2026.

4:28 PM ET Form 4
Insider Selling

Clover Health Investments CEO, Counterpart Health Conrad Wai Sells $1.42M of Stock

Conrad Wai, CEO, Counterpart Health, sold 300,000 shares of Clover Health Investments, Corp. at $4.72 a share, worth $1.42M in total on Sep 15, 2026. Shares held after the trade: 1,170,056 (-20.4%).

Value
$1.42M
Shares
300,000
Price
$4.72
Role
CEO, Counterpart Health
Holding change
-20.4%
Trade date
Sep 15, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.